BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 1204275)

  • 1. Quinine-induced alterations in drug disposition.
    Berlin CM; Stackman JM; Vesell ES
    Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anomalous results of studies on drug interaction in man. III. Disulfiram and antipyrine.
    Vesell ES; Passananti T; Glenwright PA
    Pharmacology; 1975; 13(6):481-91. PubMed ID: 1221431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of capsaicin on the pharmacokinetics of antipyrine, theophylline and quinine in rats.
    Wanwimolruk S; Nyika S; Kepple M; Ferry DG; Clark CR
    J Pharm Pharmacol; 1993 Jul; 45(7):618-21. PubMed ID: 8105056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.
    Vesell ES; Passananti GT; Glenwright PA; Dvorchik BH
    Clin Pharmacol Ther; 1975 Sep; 18(3):259-72. PubMed ID: 1164816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of etiocholanolone-induced fever on plasma antipyrine half-lives and metabolic clearance.
    Elin RJ; Vesell ES; Wolff SM
    Clin Pharmacol Ther; 1975 Apr; 17(4):447-57. PubMed ID: 1122686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of hydrocortisone to alter acutely antipyrine disposition.
    Shively CA; Gagliardi CL; Hartshorn RD; Vesell ES
    Clin Pharmacol Ther; 1978 Apr; 23(4):408-13. PubMed ID: 630788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disposition of quinine in plasma, red blood cells and saliva after oral and intravenous administration to healthy adult Africans.
    Salako LA; Sowunmi A
    Eur J Clin Pharmacol; 1992; 42(2):171-4. PubMed ID: 1618248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unaltered metabolism of antipyrine and tolbutamide in fasting man.
    Reidenberg MM; Vesell ES
    Clin Pharmacol Ther; 1975 Jun; 17(6):650-6. PubMed ID: 1139856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
    Breckenridge A; Burke CW; Davies DS; Orme ML
    Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of certain drugs in the domesticated goat.
    Boulos BM; Jenkins WL; Davis LE
    Am J Vet Res; 1972 May; 33(5):943-52. PubMed ID: 5023053
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of antipyrine in epileptic patients.
    Rimmer EM; Routledge PA; Tsanaclis LM; Richens A
    Br J Clin Pharmacol; 1986 May; 21(5):511-4. PubMed ID: 3718808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced induction of drug metabolism in the elderly.
    Salem SA; Rajjayabun P; Shepherd AM; Stevenson IH
    Age Ageing; 1978 May; 7(2):68-73. PubMed ID: 665427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies of the different metabolic pathways of antipyrine in man. Oral versus i.v. administration and the influence of urinary collection time.
    Danhof M; van Zuilen A; Boeijinga JK; Breimer DD
    Eur J Clin Pharmacol; 1982; 21(5):433-41. PubMed ID: 7075648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of single dose kinetics of imipramine, nortriptyline and antipyrine in man.
    Gram LF; Andreasen PB; Overo KF; Christiansen J
    Psychopharmacology (Berl); 1976 Oct; 50(1):21-7. PubMed ID: 827758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of sulfamerazine and antipyrine in neonatal and young lambs.
    De Backer P; Belpaire FM; Bogaert MG; Debackere M
    Am J Vet Res; 1982 Oct; 43(10):1744-51. PubMed ID: 7149373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent pharmacokinetics of antipyrine in the rat.
    Pollack GM; Li RC; Shen DD
    Res Commun Chem Pathol Pharmacol; 1984 Apr; 44(1):69-81. PubMed ID: 6729251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.